E-Clinical Solutions Market Segmentation by Product (CDMS, EDC, CTMS, eCOA, RTMS, eTMF, Analytics, and Safety); by Mode of Delivery (Web-based, On-premise, and Cloud-based); by End User (Pharmaceutical/Biopharma Companies, Contract Research Organizations (CROs), and Hospitals)-Global Demand Analysis & Opportunity Outlook 2031
-
Product Code:
RP-ID-10070550 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global E-Clinical Solutions Market Highlights Over 2022 - 2031
The global e-clinical solutions market is estimated to garner around USD 1.5 Billion in revenue by 2031 by growing at a CAGR of nearly 13% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to enormous data increasing from the healthcare industry, the rising number of clinical trials, and government emphasis on clinical research. Additionally, growing R&D expenditure on drug development by pharma-biotech companies is also driving the growth of the market. For instance, according to the World Economic Forum, as of 2019, hospitals produce around 50 petabytes of data per year. The information covers a variety of aspects, like clinical notes, lab tests, medical images, sensor readings, genomics, and operational and financial data. These aspects are driving the demand for e-clinical solutions.
CLICK TO DOWNLOAD A SAMPLE REPORT
The COVID-19 pandemic has had a positive impact on the e-clinical solutions market owing to the high adoption of e-technologies on the back of expanded healthcare systems. E-clinical solutions are being utilized to provide strategic support in the distribution of essential services.
However, high costs associated with advanced e-clinical software solutions, and the lack of skilled professionals are the key factors restraining the growth of the market.
The market is segmented by mode of delivery into web-based, on-premise, and cloud-based, out of which, the web-based segment is anticipated to hold the largest share of the market. The segment can be attributed to related benefits, such as easy accessibility, usability, and lower investments required. Web-hosted products are easily customizable, owing to which, providers can modify the presentation of information for different user groups.
Global E-Clinical Solutions Market Regional Synopsis
Regionally, the global e-clinical solutions market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region is estimated to witness significant growth over the forecast period on the back of rising government contributions to support clinical trials, continuous product development, and new product launches by e-clinical solution traders. Additionally, growth in the number of partnerships for new drug development is further driving the demand for e-clinical solutions in the region.
On the other hand, the Asia Pacific region is predicted to witness the fastest growth during the forecast period. The growth is attributed to rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and infectious diseases. Moreover, the presence of large urban population and an increase in diagnostic services are expected to drive the number of admissions into hospitals, which in turn, is expected to increase the amount of data being generated online. The rising number of pharmaceutical companies in developing Asian countries, such as China, India, Taiwan, and Korea have also increased growth opportunities for the e-clinical solutions market in the region.
Market Segmentation
Our in-depth analysis of the global e-clinical solutions market includes the following segments:
By Product
-
CDMS
-
EDC
-
CTMS
-
eCOA
-
RTMS
-
eTMF
-
Analytics
-
Safety
By Mode of Delivery
-
Web-based
-
On-premise
-
Cloud-based
By End-User
-
Pharmaceutical/Biopharma Companies
-
Contract Research Organizations (CROs)
-
Hospitals
Growth Drivers and Challenges Impacting the Growth of the Global E-Clinical Solutions Market
Growth Drivers
-
Rising number of clinical trials, and enormous data increasing from the healthcare industry
-
Government emphasis on clinical research, and growing R&D expenditure
Challenges
-
High costs associated with advanced e-clinical software solutions
-
Lack of skilled professionals
Key Companies Dominating the Global E-Clinical Solutions Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global e-clinical solutions market that are included in our report are Parexel International Corporation, eClinical Solutions LLC., Signant Health, Datatrak Int., MaxisIT, Advarra, FHI Clinical Inc., Clinical Ink, Oracle, Clario, and others.
Latest Developments in the Global E-Clinical Solutions Market:
-
April 2021: Signant Health released SmartSignals eConsent, which expanded electronic informed consent offerings, and enhanced capabilities, providing functionality updates.
-
August 2020: GI Partners announced acquisition of a major share of Clinical Ink to accelerate Clinical Ink’s innovation in clinical trial workflow solutions.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
Rising number of clinical trials, enormous data increasing from the healthcare industry, government emphasis on clinical research, and growing R&D expenditure are the major factors driving the growth of the market.
The market is anticipated to attain a CAGR of ~13% over the forecast period, i.e., 2022-2031.
High costs associated with advanced e-clinical software solutions, and lack of skilled professionals are estimated to hamper the market growth.
Asia Pacific region is anticipated to provide more business opportunities over the forecast period for the growth of the market.
The major players in the market are Parexel International Corporation, eClinical Solutions LLC., Signant Health, Datatrak Int., MaxisIT, Advarra, FHI Clinical Inc., Clinical Ink, Oracle, Clario, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product, mode of delivery, end user, and by region.
The web-based segment is anticipated to hold largest market size in value and display significant growth opportunities.
Please enter your personal details below
- Parexel International Corporation
- eClinical Solutions LLC.
- Signant Health
- Datatrak Int.
- MaxisIT
- Advarra
- FHI Clinical Inc.
- Clinical Ink
- Oracle
- Clario